Antiphospholipid syndrome and its relationship with strokes

Antiphospholipid syndrome (APS) is an autoimmune disorder that affects the circulatory system, increasing the risk of clot formation in arteries and veins. This syndrome not only has serious implications for overall health but is also closely linked to thrombotic events such as stroke.

What is antiphospholipid syndrome?

APS is a disorder in which the immune system produces abnormal antibodies called antiphospholipid antibodies (aPL). These target phospholipids, essential components of cell membranes, disrupting normal blood coagulation.

The syndrome may present as:

1. Primary: not associated with another autoimmune disease.
2. Secondary: associated with other diseases such as systemic lupus erythematosus (SLE).

Causes and risk factors

Although the exact cause of APS is unknown, its origin is associated with autoimmune and genetic factors. Risk factors include:

• Genetic predisposition.
• Autoimmune diseases such as lupus.
• Viral or bacterial infections that may trigger antibody production.
• Use of certain medications, such as hormonal contraceptives.

Additionally, factors such as smoking, obesity, and physical inactivity may increase the risk of complications related to APS.

Main symptoms of antiphospholipid syndrome

APS is primarily characterized by issues related to abnormal blood clotting. Symptoms vary depending on the affected organ, but the most common include:

• Deep vein thrombosis (DVT): swelling and pain in the legs due to clots in the deep veins.
• Pulmonary embolism: shortness of breath and chest pain caused by clots that travel to the lungs.
• Obstetric complications: recurrent miscarriages, preeclampsia, or fetal growth restriction.
• Stroke: caused by clots that obstruct blood flow to the brain.

Relationship between antiphospholipid syndrome and strokes

APS is a significant cause of ischemic stroke, especially in young individuals without traditional risk factors such as hypertension or diabetes.

Antiphospholipid antibodies create a hypercoagulable state, increasing the likelihood of clot formation in cerebral arteries. These clots can block blood flow and cause irreversible brain damage.

Additionally, APS may also be associated with other cerebrovascular events such as:

• Transient ischemic attack: brief episodes of interrupted blood flow to the brain, with symptoms resolving in less than 24 hours.
• Cerebral venous sinus thrombosis: a rare type of stroke caused by clots in the veins of the brain.

Diagnosis of antiphospholipid syndrome

The diagnosis of APS is based on a combination of clinical findings and laboratory tests. The most commonly used tests include:

1. Antiphospholipid antibody tests: detection of antibodies such as lupus anticoagulant, anticardiolipin, and anti-beta-2 glycoprotein I.
2. Coagulation studies: to assess hypercoagulability in patients suspected of having APS.
3. Medical imaging: such as Doppler ultrasounds, computed tomography scans, and magnetic resonance imaging to identify thrombosis or organ damage.

Treatment of antiphospholipid syndrome

The treatment of APS aims to prevent the formation of new clots and minimize the risk of serious complications such as stroke.

1. Anticoagulants:
   • Medications such as warfarin or heparin are prescribed to reduce excessive coagulation.
   • In pregnant women, low molecular weight heparin is used instead of warfarin, as warfarin can cause fetal malformations.
2. Antiplatelet agents:
   • Low-dose aspirin may be useful in some patients to prevent recurrent thrombosis.
3. Treatment of underlying diseases:
   • In cases of secondary APS, managing the underlying autoimmune disease (such as lupus) is key to reducing symptoms and the risk of complications.
4. Lifestyle changes:
   • Quitting smoking, maintaining a healthy weight, and engaging in regular physical activity are essential to reduce the risk of thrombosis.

Stroke prevention in patients with APS

Given the high risk of stroke associated with APS, specific preventive measures should be taken:

• Regular monitoring of anticoagulation levels through laboratory testing.
• Strict control of risk factors such as hypertension, elevated cholesterol, and diabetes.
• Prophylactic use of anticoagulants in high-risk situations such as surgeries or prolonged periods of immobility.

Conclusion

Antiphospholipid syndrome is a complex autoimmune disease that can have serious consequences if not diagnosed and treated promptly. Its association with stroke highlights the importance of comprehensive and preventive medical care.

Recognizing symptoms, obtaining an early diagnosis, and following appropriate treatment can make a significant difference in the quality of life of patients with APS, substantially reducing the risk of thrombotic and cerebrovascular complications.

If you would like more information about NeuroAiD II, please fill out this contact form.